Smith, C R <br/><br/>
Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial.  [electronic resource] 

 -  Annals of internal medicine  Oct 1984 
 - 469-77 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0003-4819 
<br/><br/><label>Standard No.: </label>10.7326/0003-4819-101-4-469  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Bacterial Infections--drug therapy<br/>Cefotaxime--adverse effects<br/>Clinical Trials as Topic<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Enterobacter<br/>Enterobacteriaceae Infections--drug therapy<br/>Escherichia coli Infections--drug therapy<br/>Female<br/>Humans<br/>Infusions, Parenteral<br/>Kidney Diseases--chemically induced<br/>Male<br/>Middle Aged<br/>Nafcillin--administration & dosage<br/>Penicillin Resistance<br/>Prognosis<br/>Pseudomonas Infections--drug therapy<br/>Random Allocation<br/>Tobramycin--administration & dosage<br/>Urinary Tract Infections--drug therapy